Fibrates are a class of lipid-modifying agents that activate peroxisome proliferator-activated receptor alpha (PPARα), leading to increased lipolysis and reduced triglyceride levels. They are clinically important for managing hypertriglyceridaemia and reducing cardiovascular risk in patients with dyslipidaemia. A key consideration is their potential to cause myopathy, especially when combined with statins.